Literature DB >> 12141021

Multispecialty physician practices: fixed and variable costs, and economies of scale.

Thomas P Weil1.   

Abstract

Medical Group Management Association survey data from 1955 to 1999 was to assess fixed compared to variable cost and the existence of economies of scale among single- and multispecialty groups. During these intervening 44 years, physician operating costs were estimated to increase roughly three times the consumer price index. Among the multispecialty groups in 1999 at least 85% of total medical revenues were considered fixed costs when including a physician's compensation and fringe benefits. On the basis of relative value units (RVUs), 10 practitioners provided the maximum economies of scale. However, for multispecialty groups, based on a physician's total compensation, optimal efficiency occurred between 26 and 50 doctors. Those multispecialty practices with 51 or more MDs are thought to be "less efficient" for several reasons: they deliver care on multisites, experience a higher percentage of managed care patients, and are less effective in controlling their peers' use of time and resources.

Entities:  

Mesh:

Year:  2002        PMID: 12141021     DOI: 10.1097/00004479-200207000-00010

Source DB:  PubMed          Journal:  J Ambul Care Manage        ISSN: 0148-9917


  4 in total

1.  Multispecialty clinic practice.

Authors:  David A Margolin; David E Beck
Journal:  Clin Colon Rectal Surg       Date:  2011-06

2.  The effect of physician and health plan market concentration on prices in commercial health insurance markets.

Authors:  John E Schneider; Pengxiang Li; Donald G Klepser; N Andrew Peterson; Timothy T Brown; Richard M Scheffler
Journal:  Int J Health Care Finance Econ       Date:  2008-03

3.  Multispecialty clinic practice.

Authors:  David E Beck; David A Margolin
Journal:  Clin Colon Rectal Surg       Date:  2006-08

Review 4.  Measuring Changes in the Economics of Medical Practice.

Authors:  Christopher Fleming; Eugene Rich; Catherine DesRoches; James Reschovsky; Rachel Kogan
Journal:  J Gen Intern Med       Date:  2015-08       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.